NCT03986229

Brief Summary

Studies have shown the existence of a proprioceptive deficit in patients with Ehlers Danlos Syndrome (EDS) (genetic pathology of connective tissue with hypermobility, multifactor joint instability). A study dating from 2010 showed a qualitative improvement in disability when wearing compression garments (CG) in this pathology, particularly in the fields of proprioception and balance. The purpose of this study is to quantify the effect of CG on standing static balance in patients with EDS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 14, 2019

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2022

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

2.9 years

First QC Date

June 11, 2019

Last Update Submit

December 14, 2022

Conditions

Keywords

ehlers-danlos syndromestatic balancecustom compression garments

Outcome Measures

Primary Outcomes (2)

  • Evaluate the variation in the travel speed of the "center of pressure" (COP) with compression garments

    Each patient will benefit from 2 posturological evaluations, namely without CG (treatment A) and with CG (treatment B).

    15 minutes

  • Evaluate the variation in the travel speed of the "center of pressure" without compression garments.

    Evaluate the variation in the travel speed of the "center of pressure" without compression garments. Each patient will benefit from 2 posturological evaluations, namely without CG (treatment A) and with CG (treatment B).

    30 minutes

Secondary Outcomes (2)

  • Evaluate the amplitude of the antero-posterior and lateral oscillations without compression garments

    15 minutes

  • Evaluate the amplitude of the antero-posterior and lateral oscillations without compression garments

    30 minutes

Study Arms (2)

With compression garments

ACTIVE COMPARATOR

Evaluation of the variation in the travel speed of the "center of pressure" with compression garments and the standing static balance.

Other: Evaluate the variation in the travel speed of the "center of pressure" with and without compression garments.

Without compression garments

ACTIVE COMPARATOR

Evaluation of the variation in the travel speed of the "center of pressure" with compression garments and the standing static balance.

Other: Evaluate the variation in the travel speed of the "center of pressure" with and without compression garments.

Interventions

Each evaluation will be done according to the following protocol: * Evaluation of the pain * Berg test * One test per condition starting with open eyes * Standardized instructions: * Break about 15 minutes (wash-out) between each test. * Both conditions will be tested on the same day. * Evaluation in an environment free from visual and audible interference.

With compression garmentsWithout compression garments

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • EDS patients over 18 years of age walking around without technical assistance.
  • Patients will need to be diagnosed both during the interview (presence of a family history, hypermobility and joint instability that has been evolving for years) and with a guide for analysis from EDS to AP-HP.
  • Beighton's score must be 5/9 or higher.
  • Free from any other pathology likely to have an impact on the balance.
  • Patient with a CG as part of his or her management of the EDS
  • Sufficient understanding to understand the objectives of the study and give consent.
  • Patient affiliated or benefiting from a social security scheme
  • Allergies to one of the components (Polyamide and Elastane) of the CG
  • Recent compression garments less than 6 months old.

You may not qualify if:

  • Patient under guardianship, curators, justice protection.
  • Comorbidity likely to influence balance.
  • Significant pain (assessed by the patient) induced by the use of CG.
  • Any acute event requires the postponement of the assessment to ensure that the patient's progress is in the usual conditions.
  • Any acute pathology having an impact on the musculoskeletal system and/or general condition.
  • Pregnancy/breastfeeding
  • Compression garments over 6 months old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Medecine physique et réadaptation

Toulouse, Salies Du Salat, 31260, France

Location

MeSH Terms

Conditions

Ehlers-Danlos Syndrome

Condition Hierarchy (Ancestors)

Hemostatic DisordersVascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesSkin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticGenetic Diseases, InbornCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • Thomas Van Den Bossche

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: 15 patients exposed to the AB sequence and 15 patients exposed to the BA sequence
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2019

First Posted

June 14, 2019

Study Start

April 10, 2019

Primary Completion

March 15, 2022

Study Completion

March 15, 2022

Last Updated

December 15, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations